Valuation: GI Dynamics, Inc.

Market Cap 440K 395K 365K 331K 618K 41.95M 626K 4.37M 1.74M 21.95M 1.65M 1.62M 69.69M P/E 2019
-1.12x
P/E 2020 -0.03x
Enterprise Value 3.28M 2.94M 2.72M 2.46M 4.6M 312M 4.66M 32.53M 12.95M 163M 12.31M 12.05M 519M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
-
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Chief Executive Officer - 05/08/2025
Director of Finance/CFO 57 01/08/2025
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Director/Board Member - 20/10/2020
Director/Board Member - -
Director/Board Member 69 01/10/2023
Date Insider Type Main position Quantity % Market Cap. Importance
28/1/21 Free

Chairman

1,384,483 0.4875%
28/1/21 Free

Chief Executive Officer

11,075,869 3.8998%

Financials

2019 2020
Net sales - -
Net income -17.33M -15.55M -14.38M -13.02M -24.33M -1.65B -24.62M -172M -68.47M -864M -65.04M -63.67M -2.74B -11.14M -9.99M -9.24M -8.37M -15.63M -1.06B -15.82M -110M -43.99M -555M -41.79M -40.91M -1.76B
Net Debt 2.89M 2.59M 2.39M 2.17M 4.05M 275M 4.1M 28.63M 11.4M 144M 10.83M 10.61M 457M 2.84M 2.55M 2.35M 2.13M 3.98M 270M 4.03M 28.16M 11.21M 141M 10.65M 10.43M 449M
Logo GI Dynamics, Inc.
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Employees
-
Sector
-
  1. Stock Market
  2. Stocks
  3. GIDYL Stock